Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany.
This study examined characteristics and treatment persistence among patients prescribed oral anticoagulants (OACs) for stroke prevention in non-valvular atrial fibrillation (NVAF). We identified 15,244 patients (51.8% male, 72.7% aged ≥70) with NVAF and no prior OAC therapy who were prescribed apixa...
Main Authors: | Shuk-Li Collings, Cinira Lefèvre, Michelle E Johnson, David Evans, Guido Hack, Gillian Stynes, Andrew Maguire |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5634552?pdf=render |
Similar Items
-
Newer Anticoagulants for Non-Valvular Atrial Fibrillation
by: Joseph M. Harburger, et al.
Published: (2012-05-01) -
Anticoagulation Therapy for Non-valvular Atrial Fibrillation: A Mini-Review
by: Jia Wu, et al.
Published: (2020-07-01) -
Current strategies of anticoagulation therapy for patients with non-valvular atrial fibrillation
by: Masahiro Yasaka
Published: (2012-12-01) -
Risk stratification and anticoagulation in low-risk non-valvular atrial fibrillation
by: Arash Arya
Published: (2013-01-01) -
Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation
by: Song T, et al.
Published: (2021-03-01)